WuXi PharmaTech Forms Alliance with Shanghai Notary Public Office to Reinforce Intellectual Property Protection
SHANGHAI, China, April 19 /PRNewswire/ -- WuXi PharmaTech (www.pharmatechs.com), a leading chemistry-based R&D service company located in Shanghai, recently agreed to collaborate with the Shanghai Notary Public Office, a notary agent appointed by the Chinese federal government, to use notarization to reinforce the protection of intellectual property and trade secrets of companies engaged in technology research. The initiative bolsters WuXi PharmaTech's ability to safeguard the intellectual property protection to its customers around the world. (Photo: http://www.newscom.com/cgi-bin/prnh/20040419/PHM047) As an official notary agency appointed by Chinese federal government, the Shanghai Notary Public Office will provide WuXi PharmaTech with reliable notarization services for contracts, agreements, certificates and other legal instruments, and will also provide consulting services regarding legal issues and regulations relating to intellectual property protection. The Shanghai Municipal Government takes the view that "Technological Innovation is the Only Way to Prosperity and Development for Shanghai City." The collaboration with WuXi PharmaTech aims to implement this underlying commercial development strategy by adding effective mechanisms to protect intellectual property protection in order to encourage innovation. At the public signing ceremony with the Shanghai Notary Office, Dr. Ge Li, the Chairman and CEO of WuXi PharmaTech, noted: "This agreement demonstrates the Chinese government's strong commitment to intellectual property protection. WuXi PharmaTech is proud to assist in this important initiative. Through this collaboration, WuXi PharmaTech continues its leadership role in pioneering approaches to protect our customers' intellectual property in China, which is a strategic priority for our company." About WuXi PharmaTech WuXi PharmaTech is a contract chemistry research and product development services company located in the WaiGaoQiao Free Trade Zone of Shanghai. Founded by a veteran of the US biotechnology industry, WuXi PharmaTech provides customers access to cost-effective world-class medicinal chemistry from a state-of-the-art research chemistry laboratory in Shanghai. The company's current customers include fourteen of the world's twenty largest pharmaceutical companies as well as dozens of prominent biotech companies. WuXi PharmaTech's laboratories are equipped with state-of-the-art instrumentation operated by experienced scientists to ensure high throughput synthesis combined with tight quality control and precise analysis. The company conducts custom synthesis, process research, scale up services and bulk synthesis of pharmaceutical intermediates. For more information, please contact: Shengxu Zhao Business Development Department WuXi PharmaTech Co. Ltd. Phone: 86-21-50460095, 50462435 Fax: 86-21-50461087 firstname.lastname@example.org Web Site: www.pharmatechs.com
SOURCE WuXi PharmaTech Co. Ltd.
More by this Source
WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
Feb 08, 2013, 11:39 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.